Literature DB >> 23907585

Sturge-weber syndrome.

Catherine D Bachur1, Anne M Comi.   

Abstract

OPINION STATEMENT: We try to see the babies prior to the onset of symptoms so that their parents can receive anticipatory guidance regarding seizures and how to recognize and respond to them and so that proper referrals to ophthalmology can be made. If there is any concern on history, exam, or EEG then we obtain a magnetic resonance imaging (MRI) with contrast. If presymptomatic diagnosis of brain involvement is made then treatment with low-dose aspirin is offered and if the brain involvement is extensively bilateral then an anticonvulsant such as levetiracetam is offered as well. Seizures are treated aggressively with a goal of obtaining and maintaining complete seizure suppression as much as possible often with a combination of low-dose aspirin and two anticonvulsants such as levetiracetam and oxcarbazepine. For many patients, this will provide adequate control of their seizures and stroke-like episodes. If the patient fails medical management and seizures are regular and accompanied by plateaued development, significant hemiparesis and visual field deficit and the patient is unilaterally involved and a surgical candidate then surgical management is urged. When the seizures are less regular, little or no hemiparesis or visual field deficit exist, and development is reasonable then this decision is more difficult. For bilaterally involved patients surgery is usually not a good option unless seizures are very severe and mostly coming from one side. Other therapeutic options include the ketogenic/Atkins diet and vagal nerve stimulator although in our experience these usually do not result in cessation of seizures. Endocrine problems occur with increased frequency and must be treated when they are present. The recent discovery of the somatic mutation causing Sturge-Weber syndrome holds promise for new treatment options in the future.

Entities:  

Year:  2013        PMID: 23907585      PMCID: PMC4487908          DOI: 10.1007/s11940-013-0253-6

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  55 in total

1.  Port-wine stains are more than skin-deep! Expanding the spectrum of extracutaneous manifestations of nevi flammei of the head and neck.

Authors:  Behfar Eivazi; Marion Roessler; Wolfgang Pfützner; Afshin Teymoortash; Jochen A Werner; Rudolf Happle
Journal:  Eur J Dermatol       Date:  2012 Mar-Apr       Impact factor: 3.328

2.  Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.

Authors:  Matthew D Shirley; Hao Tang; Carol J Gallione; Joseph D Baugher; Laurence P Frelin; Bernard Cohen; Paula E North; Douglas A Marchuk; Anne M Comi; Jonathan Pevsner
Journal:  N Engl J Med       Date:  2013-05-08       Impact factor: 91.245

3.  Quantitative EEG asymmetry correlates with clinical severity in unilateral Sturge-Weber syndrome.

Authors:  Laura A Hatfield; Nathan E Crone; Eric H Kossoff; Joshua B Ewen; Paula L Pyzik; Doris D M Lin; Thomas M Kelley; Anne M Comi
Journal:  Epilepsia       Date:  2007-01       Impact factor: 5.864

4.  Comorbidity of epilepsy and headache in patients with Sturge-Weber syndrome.

Authors:  Eric H Kossoff; Laura A Hatfield; Karen L Ball; Anne M Comi
Journal:  J Child Neurol       Date:  2005-08       Impact factor: 1.987

5.  Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication.

Authors:  Leena K Vainionpää; Kirsi Mikkonen; Johanna Rättyä; Mikael Knip; Arto J Pakarinen; Vilho V Myllylä; Jouko I T Isojärvi
Journal:  Epilepsia       Date:  2004-03       Impact factor: 5.864

6.  Behavioral and academic problems in children with Sturge-Weber syndrome: differences between children with and without seizures.

Authors:  Darcy Raches; Merrill Hiscock; Lynn Chapieski
Journal:  Epilepsy Behav       Date:  2012-09-20       Impact factor: 2.937

7.  Use of latanoprost in the treatment of glaucoma associated with Sturge-Weber syndrome.

Authors:  C B Yang; S F Freedman; J S Myers; E G Buckley; L W Herndon; R R Allingham
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

8.  Growth hormone deficiency in Sturge-Weber syndrome.

Authors:  R S Miller; K L Ball; A M Comi; E L Germain-Lee
Journal:  Arch Dis Child       Date:  2006-04       Impact factor: 3.791

9.  Prognosis in Sturge-Weber disease: comparison of unihemispheric and bihemispheric involvement.

Authors:  E M Bebin; M R Gomez
Journal:  J Child Neurol       Date:  1988-07       Impact factor: 1.987

10.  Central hypothyroidism and Sturge-Weber syndrome.

Authors:  Anne M Comi; Sridevi Bellamkonda; Lisa M Ferenc; Bernard A Cohen; Emily L Germain-Lee
Journal:  Pediatr Neurol       Date:  2008-07       Impact factor: 3.372

View more
  9 in total

Review 1.  Current Therapeutic Options in Sturge-Weber Syndrome.

Authors:  Anne Comi
Journal:  Semin Pediatr Neurol       Date:  2015-11-11       Impact factor: 1.636

Review 2.  Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review.

Authors:  Akash Kumar; Diane B Zastrow; Elijah J Kravets; Daniah Beleford; Maura R Z Ruzhnikov; Megan E Grove; Annika M Dries; Jennefer N Kohler; Daryl M Waggott; Yaping Yang; Yong Huang; Katherine M Mackenzie; Christine M Eng; Paul G Fisher; Euan A Ashley; Joyce M Teng; David A Stevenson; Joseph T Shieh; Matthew T Wheeler; Jonathan A Bernstein
Journal:  Am J Med Genet A       Date:  2019-03-28       Impact factor: 2.802

Review 3.  A Multidisciplinary Consensus for Clinical Care and Research Needs for Sturge-Weber Syndrome.

Authors:  Alejandro J De la Torre; Aimee F Luat; Csaba Juhász; Mai Lan Ho; Davis P Argersinger; Kara M Cavuoto; Mabel Enriquez-Algeciras; Stephanie Tikkanen; Paula North; Craig N Burkhart; Harry T Chugani; Karen L Ball; Anna Lecticia Pinto; Jeffrey A Loeb
Journal:  Pediatr Neurol       Date:  2018-04-18       Impact factor: 3.372

4.  A novel somatic mutation in GNAQ in a capillary malformation provides insight into molecular pathogenesis.

Authors:  F Galeffi; D A Snellings; S E Wetzel-Strong; N Kastelic; J Bullock; C J Gallione; P E North; D A Marchuk
Journal:  Angiogenesis       Date:  2022-05-30       Impact factor: 10.658

Review 5.  [Sturge-Weber syndrome].

Authors:  W Reith; U Yilmaz; A Zimmer
Journal:  Radiologe       Date:  2013-12       Impact factor: 0.635

6.  Anticonvulsant Efficacy in Sturge-Weber Syndrome.

Authors:  Emma H Kaplan; Eric H Kossoff; Catherine D Bachur; Milton Gholston; Jihoon Hahn; Matthew Widlus; Anne M Comi
Journal:  Pediatr Neurol       Date:  2016-01-11       Impact factor: 3.372

7.  Cognitive and motor outcomes in children with unilateral Sturge-Weber syndrome: Effect of age at seizure onset and side of brain involvement.

Authors:  Aimee F Luat; Michael E Behen; Harry T Chugani; Csaba Juhász
Journal:  Epilepsy Behav       Date:  2018-02-03       Impact factor: 2.937

Review 8.  Sturge-Weber syndrome: an update on the relevant issues for neurosurgeons.

Authors:  Federico Bianchi; Anna Maria Auricchio; Domenica Immacolata Battaglia; Daniela Rosaria Pia Chieffo; Luca Massimi
Journal:  Childs Nerv Syst       Date:  2020-06-21       Impact factor: 1.475

9.  Vertical parasagittal hemispherotomy for Sturge-Weber syndrome in early infancy: case report and literature review.

Authors:  Xiangyu Liu; Taisuke Otsuki; Akio Takahashi; Takanobu Kaido
Journal:  Springerplus       Date:  2016-08-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.